We are live on ! Find out more
FP

Factorial Partners Portfolio holdings

AUM $138M
1-Year Est. Return 25.59%
This Fund
S&P 500
This Quarter Est. Return
+17.21%
1 Year Est. Return
+25.59%
3 Year Est. Return
+78.35%
5 Year Est. Return
+78.52%
10 Year Est. Return
AUM
$158M
AUM Growth
+$21M
Cap. Flow
-$452K
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.34%
Holding
93
New
6
Increased
30
Reduced
24
Closed
13

Top Buys

Rank Stock Value
1
KLG
WK Kellogg Co
KLG
+$3.38M
2
SYF icon
Synchrony
SYF
+$1.36M
3
UNH icon
UnitedHealth
UNH
+$1.19M
4
CPAY icon
Corpay
CPAY
+$1.12M
5
ABG icon
Asbury Automotive
ABG
+$951K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.43M
2
CSX icon
CSX Corp
CSX
+$1.2M
3
RGA icon
Reinsurance Group of America
RGA
+$1.14M
4
PLAY icon
Dave & Buster's
PLAY
+$1.08M
5
K
Kellanova
K
+$896K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.23%
2 Financials 21.78%
3 Industrials 18.24%
4 Healthcare 13.39%
5 Technology 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMHC icon
26
Taylor Morrison
TMHC
$2.45M 1.55%
46,000
ALSN icon
27
Allison Transmission
ALSN
$9.98B
$2.44M 1.55%
42,000
-1,000
-2% -$55.8K
TPH
28
DELISTED
Tri Pointe Homes
TPH
$2.44M 1.54%
68,900
+10,000
+17% +$291K
TNL icon
29
Travel + Leisure Co
TNL
$4.64B
$2.23M 1.41%
57,000
+100
+0.2% +$3.63K
RSP icon
30
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$2.19M 1.39%
13,900
+5,700
+70% +$828K
CSX icon
31
CSX Corp
CSX
$95.6B
$2.17M 1.37%
62,500
-37,800
-38% -$1.2M
BMY icon
32
Bristol-Myers Squibb
BMY
$128B
$2.16M 1.36%
42,000
-8,100
-16% -$425K
ABG icon
33
Asbury Automotive
ABG
$4.23B
$2.14M 1.35%
9,500
+4,500
+90% +$951K
MBC icon
34
MasterBrand
MBC
$1.11B
$2.11M 1.34%
142,400
+20,000
+16% +$256K
VTRS icon
35
Viatris
VTRS
$20.6B
$2.11M 1.33%
194,700
+2,000
+1% +$19.2K
ZIMV
36
DELISTED
ZimVie
ZIMV
$2.03M 1.29%
114,400
-12,000
-9% -$121K
LAD icon
37
Lithia Motors
LAD
$7.83B
$2.01M 1.27%
6,100
MSM icon
38
MSC Industrial Direct
MSM
$6.98B
$1.87M 1.19%
18,500
+1,500
+9% +$148K
VTS icon
39
Vitesse Energy
VTS
$638M
$1.82M 1.15%
83,000
+9,000
+12% +$208K
EAT icon
40
Brinker International
EAT
$8.37B
$1.74M 1.1%
40,300
ACI icon
41
Albertsons Companies
ACI
$5.6B
$1.7M 1.08%
74,000
+2,000
+3% +$44.2K
SYF icon
42
Synchrony
SYF
$24.2B
$1.64M 1.04%
+43,000
New +$1.36M
NOMD icon
43
Nomad Foods
NOMD
$1.67B
$1.64M 1.04%
96,500
+8,000
+9% +$124K
MDC
44
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.62M 1.03%
29,400
+2,600
+10% +$115K
GNTX icon
45
Gentex
GNTX
$4.83B
$1.51M 0.95%
46,100
+8,000
+21% +$247K
KBH icon
46
KB Home
KBH
$3.53B
$1.51M 0.95%
24,100
RDN icon
47
Radian Group
RDN
$5.21B
$1.5M 0.95%
52,500
+10,000
+24% +$263K
DIN icon
48
Dine Brands
DIN
$446M
$1.49M 0.94%
30,000
K
49
DELISTED
Kellanova
K
$1.46M 0.93%
26,200
-17,146
-40% -$896K
OSUR icon
50
OraSure Technologies
OSUR
$274M
$1.34M 0.85%
163,000

Similar funds

Factorial Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Factorial Partners held 93 positions worth $158M, up 15% from $137M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Factorial Partners's Q4 2023 filing shows 6 new, 30 increased, 24 reduced and 13 closed positions. Its largest new stake was WK Kellogg Co: 300,000 shares worth $3.94M. The largest sale was Pfizer, an estimated $1.43M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • Factorial Partners's largest Q4 2023 buy was WK Kellogg Co: 300,000 shares worth $3.94M.
  • Factorial Partners added most to UnitedHealth in Q4 2023, an estimated $1.19M increase.
  • Factorial Partners's biggest Q4 2023 reduction was CSX Corp, cutting an estimated $1.2M.
  • Factorial Partners fully exited Pfizer in Q4 2023, selling an estimated $1.43M.
  • Factorial Partners's ten largest holdings make up 29% of its $158M portfolio in Q4 2023.
  • Factorial Partners opened 6 new positions and closed 13 in Q4 2023.
  • Factorial Partners's portfolio value rose 15% quarter-over-quarter to $158M.

Based on Factorial Partners's 13F filing for Q4 2023, filed 13 Feb 2024.